Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Conclusions: With continued high rates of adult obesity and DM, and an aging population, NAFLD‐related liver disease and mortality will increase in the US. Strategies to slow the growth of NAFLD cases and therapeutic options are necessary to mitigate disease burden. This article is protected by copyright. All rights reserved.
Source: Hepatology - Category: Internal Medicine Authors: Chris Estes, Homie Razavi, Rohit Loomba, Zobair Younossi, Arun J. Sanyal Tags: Steatohepatitis and Metabolic Liver Disease Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Epidemics | Epidemiology | Fatty Liver Disease (FLD) | Hepatocellular Carcinoma | History of Medicine | Internal Medicine | Liver | Liver Cancer | Liver Disease | Liver Transplant | Non-alcoholic Fatty Liver Diseases (NAFLD) | Obesity | Transplants | Urology & Nephrology